Loading…

Accuray Asia Limited and CNNC High Energy Equipment (Tianjin) Co., Ltd formed a joint venture, CNNC Accuray (Tianjin) Medical Technology Co., Ltd., to manufacture and sell radiation oncology systems in China. CIRC's subsidiary owns 51%, Accuray's 49%.
“Accuray and CIRC believe that the JV...will be uniquely positioned to serve the world's largest growth market for radiation oncology systems.”biospectrumasia.com
Summarized from public sources; check the original articles before acting on it.